Fairfax, Kirsten <br/><br/>
BAFF/BLyS inhibitors: A new prospect for treatment of systemic lupus erythematosus.  [electronic resource] 

 -  IUBMB life  Jul 2012 
 - 595-602 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1521-6551 
<br/><br/><label>Standard No.: </label>10.1002/iub.1046  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>B-Cell Activating Factor--antagonists & inhibitors<br/>Chemistry, Pharmaceutical--methods<br/>Clinical Trials, Phase III as Topic<br/>Drug Approval<br/>Drug Design<br/>European Union<br/>Humans<br/>Lupus Erythematosus, Systemic--drug therapy<br/>Mice<br/>Recombinant Fusion Proteins--therapeutic use<br/>United States<br/>United States Food and Drug Administration